Fujifilm's
Supria
Plus
CT
is
now
at
Advantage
Diagnostics!
Our
CT
has
advanced
clinical
capabilities
and
unique
features
to
provide
a
more
comfortable
experience
for
all
patients,
from
pediatric
to
adult
to
elderly,
and
offers:
-
Advanced
dose
reduction
capabilities
-
Stellar
image
quality
-
Large
and
wide
opening
-
Table
that
can
accommodate
patients
up
to
500
lbs
-
Powerful
3D
visualization
tools
Enhanced
Patient
Access
and
Comfort 
The
Access
and
Comfort
You
Expect
Supria
Plus
at
Advantage
Diagnostics
eases
the
CT
encounter,
offering:
-
Lower
radiation
dose
-
CT
scan
times
measured
in
seconds
-
A
wider
patient
table
designed
for
comfortable
positioning
-
A
lower
table
that
allows
for
easy
access
by
patients
in
wheelchairs
Better
Images
with
HiMAR
High
Quality
Metal
Artifact
Suppression
HiMAR
technology
on
Fujifilm's
Supria
Plus
is
designed
for
metal
artifact
suppression,
meaning
it
provides:
-
An
excellent
diagnostic
tool
for
patients
with
spinal
and
orthopedic
metallic
hardware
-
More
clarity
in
visualizing
high
density
structures
and
surrounding
anatomy
-
An
extended
CT
number
range
to
better
observe
details
of
metal
and
structures
with
high
CT
numbers
Advanced
Cardiac
Imaging
Calcium
Scoring
Benefits
Cardiac
Patients

Supria
Plus
is
a
powerful
diagnostic
tool
that
includes
calcium
scoring,
a
leading,
non-invasive
technology
that
provides:
-
A
valuable
quantitative
measure
of
cardiac
event
risk
(when
considered
together
with
other
risk
factors)
-
An
index
of
a
patient's
coronary
artery
plaque
burden
-
A
determination
of
the
risk
of
an
obstructive
coronary
stenosis
Lung
Screening 

Enable
Earlier
Diagnosis
of
Cancer
in
High
Risk
Patients
Fujifilm's
Supria
Plus
provides
low
dose
CT
scanning
for
high
risk
patients
to
enable
earlier
diagnosis
of
lung
cancer.
The
U.S.
Preventive
Services
Task
Force
recommends
an
annual
screening
exam
for
patients
who
meet
the
following
requirements:
-
Age
55-80
years
-
20-pack
years
or
greater
history
-
Current
smokers
or
smokers
who
quit
within
the
last
15
years
-
Written
order
following
lung
cancer
risk
counselling